Showing results (211-220 of 258) with videos related to
Sort By:
Pageof 26
Antiviral Research|June 21, 2025
Host-directed approaches in the pursuit of a cure for HIVRory A Shepherd, Kiho Tanaka, Hannah A D King, et al.Journal of Virology|August 13, 2011
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophagesKieran Cashin, Michael Roche, Jasminka Sterjovski, et al.Retrovirology|November 8, 2011
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entryMichael Roche, Martin R Jakobsen, Anne Ellett, et al.Retrovirology|September 18, 2013
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infectionKieran Cashin, Martin R Jakobsen, Jasminka Sterjovski, et al.Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.Journal of Virus Eradication|July 13, 2023
Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platformCarolin Tumpach, Catherine R Cochrane, Youry Kim, et al.International Journal of Molecular Sciences|April 14, 2026
HIV Promoters Isolated from Brain and Peripheral Tissue of Virally Suppressed PWH Are Phylogenetically and Functionally SimilarJanna Jamal Eddine, Emily K Chalmers, Jingling Zhou, et al.Journal of Medicinal Chemistry|September 29, 2006
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interactionDow Hurst, Uju Umejiego, Diane Lynch, et al.Technical Innovations & Patient Support in Radiation Oncology|April 24, 2026
Implementation of surface-guided radiotherapy for motion management in liver SBRT: A scoping review and clinical workflow developmentOrla McKivitt, Michael Roche, Kate Lawless, et al.Journal of Virology|February 25, 2011
HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropismMichael Roche, Martin R Jakobsen, Jasminka Sterjovski, et al.Pageof 26